InvestorsHub Logo
Followers 4
Posts 227
Boards Moderated 0
Alias Born 05/03/2018

Re: Megc post# 169331

Saturday, 12/29/2018 4:51:40 PM

Saturday, December 29, 2018 4:51:40 PM

Post# of 425750
The primary endpoint was significantly lower with icosapent ethyl in the secondary prevention cohort (71% of participants) but not in the smaller primary prevention cohort (NEJM JW Gen Med Jan 1 2019 and N Engl J Med 2018 Nov 10; [e-pub]).

But NOT in the smaller primary prevention cohort....what? really ? What devil in the detail am I missing....anyone?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News